Fluoropyrimidine-induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT)

Fluoropyrimidines (FP) are the backbone chemotherapy in colorectal cancer (CRC) treatment; however, their use is associated with cardiotoxicity, which is underreported. In the present study, it was aimed to prospectively determine the incidence rates and related risk factors of FP-induced cardiotoxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombardi, Pasquale, Aimar, Giacomo, Peraldo-Neia, Caterina, Bonzano, Alessandro, Depetris, Ilaria, Fenocchio, Elisabetta, Filippi, Roberto, Quarà, Virginia, Milanesio, Michela, Cavalloni, Giuliana, Gammaitoni, Loretta, Basiricò, Marco, Cagnazzo, Celeste, Ostano, Paola, Chiorino, Giovanna, Aglietta, Massimo, Leone, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827273/
https://www.ncbi.nlm.nih.gov/pubmed/36562382
http://dx.doi.org/10.3892/or.2022.8468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827273/
https://www.ncbi.nlm.nih.gov/pubmed/36562382
http://dx.doi.org/10.3892/or.2022.8468

Ejemplares similares